Hearing aids

.

Chapter 5 in Cost-Benefit Analysis and Dementia, 2022, pp 67-79 from Edward Elgar Publishing

Abstract: The third new dementia intervention is hearing aids (HAs). For the previous two interventions, independent-living cost savings measured benefits. For the HA CBA, we now focus on the QoL as the final outcome to be valued. The monetary value for the QoL is based on the value of a statistical life (VSL) literature. Hearing loss is caused by the natural aging of the auditory system and can be offset by HAs. Since interfering with activities of daily living (ADL) is our behavioural definition of dementia, it is by HAs allowing ADL to continue that HAs reduce dementia symptoms. Using a one-way fixed effects estimation method is the causal strategy for explaining why HAs reduce dementia symptoms. For each dollar of costs for HAs, there are in total over 29 dollars of benefits, which includes 1.2 benefits per dollar of costs just from the dementia benefits. Thus, HAs are clearly worthwhile.

Keywords: Development Studies; Economics and Finance; Environment; Sociology and Social Policy (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.elgaronline.com/view/9781839105753.00014.xml (application/pdf)
Our link check indicates that this URL is bad, the error code is: 503 Service Temporarily Unavailable

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:elg:eechap:19697_5

Ordering information: This item can be ordered from
http://www.e-elgar.com

Access Statistics for this chapter

More chapters in Chapters from Edward Elgar Publishing
Bibliographic data for series maintained by Darrel McCalla ().